Indian Immunologicals to double foot and mouth disease vaccine capacity

To Invest Rs 700 crore in Hyderabad for new animal vaccine facility

Indian Immunologicals (IIL), subsidiary of the National Dairy Development Board (NDDB), is setting up a new animal vaccine manufacturing facility in Hyderabad with an investment of Rs 700 crore. The facility will double its capacity to produce vaccines for the Foot and Mouth disease (FMD) to 600 mn annual doses. 

Coming up at Genome Valley Phase 3, the vaccine hub of Hyderabad, the facility will add 300 mn doses per annum capacity for FMD vaccines, and double the existing capacity. The existing facility in Gachibowli already has a capacity of 300 million doses. Production is scheduled to commence in the